Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Devazepide is a competitive and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor (IC50s: 81 pM, 45 pM, and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約 5 days | ¥ 16,000 |
5 mg | 約5 days | ¥ 29,500 |
1 mL * 10 mM (in DMSO) | 約5 days | ¥ 35,000 |
説明 | Devazepide is a competitive and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor (IC50s: 81 pM, 45 pM, and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively). |
ターゲット&IC50 | CCK receptor (guinea pig brain):245 nM, CCK receptor (rat pancreas):45 pM, CCK receptor (bovine gallbladder):81 pM |
別名 | L-364,718, MK-329 |
分子量 | 408.45 |
分子式 | C25H20N4O2 |
CAS No. | 103420-77-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Devazepide 103420-77-5 Others MK 329 MK329 L-364,718 MK-329 Inhibitor inhibitor inhibit